FILING RADAR

Connecting to SEC EDGAR… Pricing Sign in

← All filings

ENTX

Entera Bio Ltd. SEC filings

Biological Products, (No Diagnostic Substances) · Nasdaq · Incorporated in Israel

On the radar right now · 1

Nov 6, 4:15 PM ET

Entera Bio Ltd.ENTX

Earnings results · Reg FD disclosure

Filing history

2026-11-06

Quarterly report 10-Q

2026-11-06

Current report 8-K

Earnings resultsReg FD disclosure

2026-10-30

Passive 5%+ stake SCHEDULE 13G

2026-10-27

Current report 8-K

Exec/director changeReg FD disclosure

2026-10-14

Proxy statement (shareholder vote) DEF 14A

2026-10-06

Current report 8-K

Exec/director changeReg FD disclosure

2026-09-23

PRE 14A PRE 14A

2026-08-28

EFFECT EFFECT

2026-08-28

Prospectus 424B3

2026-08-21

Shelf registration (future share sales) S-3

2026-08-21

New insider's holdings 3

2026-08-18

Current report 8-K

Reg FD disclosureOther event

2026-08-12

D D

Item 06b

2026-08-07

Insider trade 4

2026-08-07

Insider trade 4

2026-08-07

Insider trade 4

2026-08-07

Insider trade 4

2026-08-07

Insider trade 4

2026-08-07

Insider trade 4

2026-08-07

Insider trade 4

2026-08-07

Insider trade 4

2026-08-07

Insider trade 4

2026-08-07

Employee stock plan shares S-8

2026-08-07

Quarterly report 10-Q

2026-08-07

Current report 8-K

Earnings resultsReg FD disclosure

2026-08-04

Passive 5%+ stake SCHEDULE 13G

2026-08-04

Passive 5%+ stake SCHEDULE 13G

2026-08-04

5%+ stake, may push for changes SCHEDULE 13D

2026-08-04

Passive 5%+ stake SCHEDULE 13G

2026-08-04

Passive 5%+ stake SCHEDULE 13G

2026-07-28

Current report 8-K

Material agreementShare sale (dilution)Exec/director change

2026-07-16

Current report 8-K

Exec/director changeBylaws changeShareholder vote

2026-07-16

Insider trade 4

2026-06-03

Proxy material DEFA14A

2026-06-03

Annual report to shareholders ARS

2026-06-03

Proxy statement (shareholder vote) DEF 14A

2026-05-15

EFFECT EFFECT

2026-05-15

Prospectus 424B3

2026-05-14

PRE 14A PRE 14A

2026-05-13

CORRESP CORRESP